"The benefits of antidepressants is based upon just one probability, one which has been debunked as non-scientific by many academics. The risks of taking antidepressants are reported side effects, including self-harm, suicidal thoughts and suicide completion. And we are **still** told by Dr's, pharmaceutical companies and medicine regulators that the benefits outweigh the risks. This is an incorrect statement.."

~ Bob Fiddaman

Monsanto Roundup Lawsuit

Friday, October 29, 2010

UNITED STATES OF AMERICA, STATES OF CALIFORNIA, DELAWARE, FLORIDA, GEORGIA, HAWAII , ILLINOIS, INDIANA, LOUISIANA, MASSACHUSETTS, MICHIGAN, NEVADA, NEW HAMPSHIRE, NEW MEXICO, NEW YORK, TENNESSEE, TEXAS, and VIRGINIA, THE DISTRICT OF COLUMBIA and THE CITIES OF CHICAGO AND NEW YORK, ex rel . CHERYL D. ECKARD,

Examples of defective and/or misidentified products that the defendants released to the United States market from the Cidra plant are:

a. Drug product that was mixed up with drug product of a different type or strength, e.g., 30mg and 10 mg tablets of an anti-depressant mixed in the same bottle, and 12.5 and 6.25 mg tablets of a heart medication mixed in the same bottle.

b. A diabetes medication that was sub-potent and/or superpotent.

c. An antibiotic ointment used to treat a skin infection common in small children that was contaminated with a microorganism associated with bacteranemia, urinary tract infections, meningitis, wound infection, and peritonitis.

d. An injectable drug used to treat nausea and vomiting in patients undergoing chemotherapy that was contaminated with micro-organisms.

Further, on information and belief, during the times relevant to this complaint employees of the defendants diverted reject drug product from the Cidra plant to black markets in Latin America. The defendants’ management failed adequately to investigate these allegations. On information and belief, this resulted in the distribution of reject drug product to the United States market and the submission of false claims for drug product that was defective.

You read it correct folks!

Antidepressants containing different dosage strengths.

Heart medication containing different strengths.

A diabetes medication with a defect.

A children's ointment that was contaminated with a microorganism associated with bacteranemia, urinary tract infections, meningitis, wound infection, and peritonitis.

And a injectable drug used to treat nausea and vomiting in patients undergoing chemotherapy that was contaminated with micro-organisms.

Not content with the piss poor management of regulating the manufacturing of medications it was also alleged that employees of GlaxoSmithKline diverted reject drug product from the Cidra plant to black markets in Latin America.

"Hey senor, you wanna buy some sheeeeeeet."

Glaxo pleaded guilty to charges brought against them and were fined $750 million.

It is claimed that none of the defective products left the Puerto Rican plant.